Cargando…

Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial

BACKGROUND: A lumbar herniated intervertebral disc (LHIVD) is a common problem that usually causes low back pain and radiating pain. The effectiveness of Bosinji, one of the herbal medicines used for low back pain and radiating pain in patient with LHIVD, has been reported in several studies; howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Goo, Bonhyuk, Kim, Sung-Jin, Kim, Eun-Jung, Nam, Dongwoo, Lee, Hyun-Jong, Kim, Jae-Soo, Park, Yeon-Cheol, Baek, Yong-Hyeon, Nam, Sang-Soo, Seo, Byung-Kwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320215/
https://www.ncbi.nlm.nih.gov/pubmed/30558079
http://dx.doi.org/10.1097/MD.0000000000013684
_version_ 1783385197642776576
author Goo, Bonhyuk
Kim, Sung-Jin
Kim, Eun-Jung
Nam, Dongwoo
Lee, Hyun-Jong
Kim, Jae-Soo
Park, Yeon-Cheol
Baek, Yong-Hyeon
Nam, Sang-Soo
Seo, Byung-Kwan
author_facet Goo, Bonhyuk
Kim, Sung-Jin
Kim, Eun-Jung
Nam, Dongwoo
Lee, Hyun-Jong
Kim, Jae-Soo
Park, Yeon-Cheol
Baek, Yong-Hyeon
Nam, Sang-Soo
Seo, Byung-Kwan
author_sort Goo, Bonhyuk
collection PubMed
description BACKGROUND: A lumbar herniated intervertebral disc (LHIVD) is a common problem that usually causes low back pain and radiating pain. The effectiveness of Bosinji, one of the herbal medicines used for low back pain and radiating pain in patient with LHIVD, has been reported in several studies; however, little clinical evidence is available owing to the methodological limitations in previous studies. Hence, the present study aims to establish the clinical evidence regarding the efficacy and safety of Bosinji in improving pain, function, and quality of life in LHIVD patients. METHOD/DESIGN: This is a multicenter, open-label, randomized, controlled, and equivalence trial with 2 parallel arms. A total of 74 patients who have low back pain and radiating pain due to LHIVD will be recruited and randomly allocated to the experimental group and control group. The patients in the experimental group and control group will take 2.5 g of Bosinji granule (1.523 g of Bosinji extract) or Loxonin tablet (60 mg of loxoprofen) 3 times a day for 6 weeks. Additionally, both groups will receive the same acupuncture treatment once a week for 6 weeks as a concurrent treatment. Changes in the 100-mm visual analogue scale (VAS) for low back pain after 6 weeks from baseline will be assessed as the primary outcome. Furthermore, the 100-mm VAS for radiating pain, Oswestry disability index (ODI), Roland–Morris disability questionnaire (RMDQ), EuroQol 5 Dimensions 5 Levels (EQ-5D-5L), global perceived effect (GPE), and deficiency syndrome of kidney index (DSKI) will be used to evaluate secondary outcomes. Outcomes will be assessed at baseline and at 3, 6, and 10 weeks after screening. For the safety evaluation, laboratory examinations including complete blood count, liver function test, renal function test, blood coagulation test, inflammation test, and urine analysis will be conducted before and after taking the medications. DISCUSSION: The results of this trial will be used to establish clinical evidence regarding the use of Bosinji with acupuncture treatment in the treatment of patients with LHIVD. TRIAL REGISTRATION NUMBER: NCT03386149 (clinicaltrials.gov) and KCT0002848 (Clinical Research Information Service of the Republic of Korea).
format Online
Article
Text
id pubmed-6320215
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63202152019-01-14 Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial Goo, Bonhyuk Kim, Sung-Jin Kim, Eun-Jung Nam, Dongwoo Lee, Hyun-Jong Kim, Jae-Soo Park, Yeon-Cheol Baek, Yong-Hyeon Nam, Sang-Soo Seo, Byung-Kwan Medicine (Baltimore) Research Article BACKGROUND: A lumbar herniated intervertebral disc (LHIVD) is a common problem that usually causes low back pain and radiating pain. The effectiveness of Bosinji, one of the herbal medicines used for low back pain and radiating pain in patient with LHIVD, has been reported in several studies; however, little clinical evidence is available owing to the methodological limitations in previous studies. Hence, the present study aims to establish the clinical evidence regarding the efficacy and safety of Bosinji in improving pain, function, and quality of life in LHIVD patients. METHOD/DESIGN: This is a multicenter, open-label, randomized, controlled, and equivalence trial with 2 parallel arms. A total of 74 patients who have low back pain and radiating pain due to LHIVD will be recruited and randomly allocated to the experimental group and control group. The patients in the experimental group and control group will take 2.5 g of Bosinji granule (1.523 g of Bosinji extract) or Loxonin tablet (60 mg of loxoprofen) 3 times a day for 6 weeks. Additionally, both groups will receive the same acupuncture treatment once a week for 6 weeks as a concurrent treatment. Changes in the 100-mm visual analogue scale (VAS) for low back pain after 6 weeks from baseline will be assessed as the primary outcome. Furthermore, the 100-mm VAS for radiating pain, Oswestry disability index (ODI), Roland–Morris disability questionnaire (RMDQ), EuroQol 5 Dimensions 5 Levels (EQ-5D-5L), global perceived effect (GPE), and deficiency syndrome of kidney index (DSKI) will be used to evaluate secondary outcomes. Outcomes will be assessed at baseline and at 3, 6, and 10 weeks after screening. For the safety evaluation, laboratory examinations including complete blood count, liver function test, renal function test, blood coagulation test, inflammation test, and urine analysis will be conducted before and after taking the medications. DISCUSSION: The results of this trial will be used to establish clinical evidence regarding the use of Bosinji with acupuncture treatment in the treatment of patients with LHIVD. TRIAL REGISTRATION NUMBER: NCT03386149 (clinicaltrials.gov) and KCT0002848 (Clinical Research Information Service of the Republic of Korea). Wolters Kluwer Health 2018-12-14 /pmc/articles/PMC6320215/ /pubmed/30558079 http://dx.doi.org/10.1097/MD.0000000000013684 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle Research Article
Goo, Bonhyuk
Kim, Sung-Jin
Kim, Eun-Jung
Nam, Dongwoo
Lee, Hyun-Jong
Kim, Jae-Soo
Park, Yeon-Cheol
Baek, Yong-Hyeon
Nam, Sang-Soo
Seo, Byung-Kwan
Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title_full Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title_fullStr Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title_full_unstemmed Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title_short Clinical research on the efficacy and safety of Bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: A protocol for a multicenter, randomized, controlled equivalence trial
title_sort clinical research on the efficacy and safety of bosinji for low back pain with radiculopathy caused by herniated intervertebral disc of the lumbar spine: a protocol for a multicenter, randomized, controlled equivalence trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320215/
https://www.ncbi.nlm.nih.gov/pubmed/30558079
http://dx.doi.org/10.1097/MD.0000000000013684
work_keys_str_mv AT goobonhyuk clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT kimsungjin clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT kimeunjung clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT namdongwoo clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT leehyunjong clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT kimjaesoo clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT parkyeoncheol clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT baekyonghyeon clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT namsangsoo clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial
AT seobyungkwan clinicalresearchontheefficacyandsafetyofbosinjiforlowbackpainwithradiculopathycausedbyherniatedintervertebraldiscofthelumbarspineaprotocolforamulticenterrandomizedcontrolledequivalencetrial